SAT-437 The Patro Adults Study of Omnitrope® for the Treatment of Adult Patients with Growth Hormone Deficiency: Latest Safety Outcomes Including Diabetes Risk

Introduction: PATRO Adults is an international, longitudinal, non-interventional study of the long-term safety and efficacy of Omnitrope® (recombinant human growth hormone, rhGH; Sandoz) in adults treated in routine clinical practice. The study provides data on the long-term safety of rhGH in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck-Peccoz, Paolo, Höybye, Charlotte, Murray, Robert, Simsek, Suat, Zabransky, Markus, Zouater, Hichem, Stalla, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551651/
http://dx.doi.org/10.1210/js.2019-SAT-437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551651/
http://dx.doi.org/10.1210/js.2019-SAT-437

Ejemplares similares